Cigna Group (CI) Expected to Release Earnings on Thursday

Cigna Group (NYSE:CI) is projected to announce its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect Cigna Group to announce earnings of $7.60 per share and revenue of $70.1399 billion for the quarter. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Parties may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:30 AM ET.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.74 earnings per share. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Trading Up 0.6%

Cigna Group stock opened at $291.35 on Tuesday. The firm has a 50-day moving average price of $286.15 and a two-hundred day moving average price of $280.80. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The firm has a market capitalization of $77.07 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.12 and a beta of 0.29. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s payout ratio is presently 26.45%.

Insider Activity at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

A number of hedge funds have recently modified their holdings of the stock. Wilkerson Advisory Group LLC acquired a new position in shares of Cigna Group in the 4th quarter valued at $25,000. Prosperity Bancshares Inc acquired a new stake in Cigna Group during the 4th quarter worth about $29,000. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group during the 4th quarter worth about $29,000. Measured Wealth Private Client Group LLC purchased a new stake in Cigna Group during the third quarter valued at about $56,000. Finally, Johnson Financial Group Inc. boosted its holdings in shares of Cigna Group by 445.9% in the third quarter. Johnson Financial Group Inc. now owns 202 shares of the health services provider’s stock worth $58,000 after buying an additional 165 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CI has been the subject of several recent analyst reports. The Goldman Sachs Group increased their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Wells Fargo & Company upped their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. Morgan Stanley raised their target price on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, Royal Bank Of Canada increased their price objective on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.